XML 1023 R12.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 6 - Fair Value Measurements and Financial Instruments
12 Months Ended
Dec. 31, 2017
Notes to Financial Statements  
Fair Value Disclosures [Text Block]
NOTE
6
– FAIR VALUE MEASUREMENTS AND FINANCIAL INSTRUMENTS
 
ASC Topic
820,
Fair Value Measurement and Disclosures
, defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. This topic also establishes a fair value hierarchy, which requires classification based on observable and unobservable inputs when measuring fair value. The fair value hierarchy distinguishes between assumptions based on market data (observable inputs) and an entity’s own assumptions (unobservable inputs). The hierarchy consists of
three
levels:
 
Level
1
– Quoted prices in active markets for identical assets and liabilities;
 
Level
2
– Inputs other than level
one
inputs that are either directly or indirectly observable; and
 
Level
3
– Unobservable inputs developed using estimates and assumptions, which are developed by the reporting entity and reflect those assumptions that a market participant would use.
 
Liabilities measured at fair value on a recurring basis are summarized as follows:
 
 
   
Fair value measurement using inputs
   
Carrying amount
 
   
Level 1
   
Level 2
   
Level 3
   
December 31,
201
7
   
December 31,
201
6
 
                                         
Financial instruments:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Series 2023 Note Derivative
  $
-0-
    $
-0-
    $
163,634
    $
163,634
    $
142,909
 
Series A Note Derivative
  $
-0-
    $
-0-
    $
1,883,630
    $
1,883,630
    $
2,033,643
 
 
The following table summarizes the activity for financial instruments at fair value using Level
3
inputs for
2017
and
2016:
 
   
201
7
   
201
6
 
Balance at beginning of year
  $
2,176,552
    $
5,138,857
 
Issuance of additional Series 2023 Notes
   
13,155
     
18,807
 
Issuance of additional Series A Notes
   
85,834
     
247,931
 
Net unrealized gain included in operations
   
(228,277
)
   
(3,229,043
)
                 
Balance at
end of year
  $
2,047,264
    $
2,176,552
 
 
The recorded value of certain financial assets and liabilities, which consist primarily of cash and cash equivalents, receivables, and accounts payable and accrued expenses approximate their fair value at
December 31, 2017
and
2016
based upon the short-term nature of the assets and liabilities. Based on borrowing rates currently available to the Company for loans with similar terms, and the remaining short-term period outstanding, the carrying value of notes payable other than PIK notes approximate fair value. The estimated fair value of the PIK Notes Payable was approximately
$11,395,208
and
$23,361,553
at
December 31, 2017
and
2016
(Level
3
), respectively.
 
For the Company's warrant and PIK note derivative liabilities, Level
3
fair value hierarchy was estimated using a Monte Carlo Model using the following assumptions:
 
 
Series 2023 Note derivative liability
 
Fair Value Measurements
 
   
Using Inputs
 
   
December 31,
2017
   
December 31,
2016
 
                 
Market price and estimated fair value of stock
  $
0.05
    $
0.12
 
Exercise price (1)
  $
0.59
    $
1.28
 
Term (years)
   
5.58
     
6.58
 
Dividend yield
   
-0-
     
-0-
 
Expected volatility
   
115.3
%
   
86.2
%
Risk-free interest rate
   
2.24
%
   
2.18
%
(
1
) Exercise price is reflective of amended Series
2023
Notes issued in
December 2017
as discussed in Note
8.
 
Series A Note derivative liability
 
Fair Value Measurements
 
   
Using Inputs
 
   
December 31,
2017
   
December 31,
2016
 
                 
Market price and estimated fair value of stock
  $
0.05
    $
0.12
 
Exercise price (1)
  $
0.40
    $
0.83
 
Term (years)
   
5.58
     
6.58
 
Dividend yield
   
-0-
     
-0-
 
Expected volatility
   
115.3
%
   
86.2
%
Risk-free interest rate
   
2.24
%
   
2.18
%
 (
1
) Exercise price is reflective of amended Series A Notes issued in
December 2017
as discussed in Note
8.